{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:36:15Z","timestamp":1774697775092,"version":"3.50.1"},"reference-count":33,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.1536\/ihj.23-330","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T22:17:30Z","timestamp":1706653050000},"page":"109-118","source":"Crossref","is-referenced-by-count":2,"title":["Ivabradine Alleviates Experimental Autoimmune Myocarditis-Mediated Myocardial Injury"],"prefix":"10.1536","volume":"65","author":[{"given":"Manlin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fourth Affiliated Hospital, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fourth Affiliated Hospital, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fourth Affiliated Hospital, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"An","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohan","family":"Li","sequence":"additional","affiliation":[{"name":"Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fourth Affiliated Hospital, Harbin Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shiheido-Watanabe Y, Maejima Y, Kasama T, <i>et al<\/i>. Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis. JACC Basic Transl Sci 2021; 6: 527-42.","DOI":"10.1016\/j.jacbts.2021.04.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liu W, Li WM, Gao C, Sun NL. Effects of atorvastatin on the Th1\/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. J Autoimmun 2005; 25: 258-63.","DOI":"10.1016\/j.jaut.2005.06.005"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-82.","DOI":"10.1161\/hc3401.095198"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kara Z, G\u00fcven B, Onay Besikci A, Y\u0131ld\u0131r\u0131m N, Altunay H. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol 2022; 916: 174551.","DOI":"10.1016\/j.ejphar.2021.174551"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lainez S, Tsantoulas C, Biel M, McNaughton PA. HCN3 ion channels: roles in sensory neuronal excitability and pain. J Physiol 2019; 597: 4661-75.","DOI":"10.1113\/JP278211"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sartiani L, Romanelli MN, Mugelli A, Cerbai E. Updates on HCN channels in the heart: function, dysfunction and pharmacology. Curr Drug Targets 2015; 16: 868-76.","DOI":"10.2174\/1389450116666150531152047"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wahl-Schott C, Biel M. HCN channels: structure, cellular regulation and physiological function. Cell Mol Life Sci 2009; 66: 470-94.","DOI":"10.1007\/s00018-008-8525-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Biel M, Schneider A, Wahl C. Cardiac HCN channels: structure, function, and modulation. Trends Cardiovasc Med 2002; 12: 206-12.","DOI":"10.1016\/S1050-1738(02)00162-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen J, Piper DR, Sanguinetti MC. Voltage sensing and activation gating of HCN pacemaker channels. Trends Cardiovasc Med 2002; 12: 42-5.","DOI":"10.1016\/S1050-1738(01)00141-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Peters CJ, Chow SS, Angoli D, <i>et al<\/i>. In situ co-distribution and functional interactions of SAP97 with sinoatrial isoforms of HCN channels. J Mol Cell Cardiol 2009; 46: 636-43.","DOI":"10.1016\/j.yjmcc.2009.01.010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 2003; 65: 453-80.","DOI":"10.1146\/annurev.physiol.65.092101.142734"},{"key":"12","unstructured":"12. Gammone MA, Riccioni G, D&apos;Orazio N. Ivabradine: a new frontier in the treatment of stable coronary artery disease and chronic heart failure. Clin Ter 2020; 171: e449-53."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Riccioni G. Ivabradine: the hope for a good treatment of ischemic heart disease. Curr Med Chem 2013; 20: 1817-23.","DOI":"10.2174\/0929867311320140002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Busseuil D, Shi Y, Mecteau M, <i>et al<\/i>. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology 2010; 117: 234-42.","DOI":"10.1159\/000322905"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yuan ML, Zhao B, Jia HP, Zhang C, Zuo XW. Sinomenine ameliorates cardiac hypertrophy by activating Nrf2\/ARE signaling pathway. Bioengineered 2021; 12: 12778-88.","DOI":"10.1080\/21655979.2021.2000195"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhong W, Darmani NA. The HCN channel blocker ZD7288 induces Emesis in the least Shrew (Cryptotis parva). Front Pharmacol 2021; 12: 647021.","DOI":"10.3389\/fphar.2021.647021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wu Y, Wang Q, Granger J, <i>et al<\/i>. HCN channels sense temperature and determine heart rate responses to heat. bioRxiv 2023; 2023.09.02.556046.","DOI":"10.1101\/2023.09.02.556046"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rivolta I, Binda A, Masi A, DiFrancesco JC. Cardiac and neuronal HCN channelopathies. Pflugers Arch 2020; 472: 931-51.","DOI":"10.1007\/s00424-020-02384-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. DiFrancesco JC, DiFrancesco D. Dysfunctional HCN ion channels in neurological diseases. Front Cell Neurosci 2015; 6: 174.","DOI":"10.3389\/fncel.2015.00071"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hennis K, Biel M, Fenske S, Wahl-Schott C. Paradigm shift: new concepts for HCN4 function in cardiac pacemaking. Pflugers Arch 2022; 474: 649-63.","DOI":"10.1007\/s00424-022-02698-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Liu J, Kasuya G, Zempo B, Nakajo K. Two HCN4 channels play functional roles in the zebrafish heart. Front Physiol 2022; 13: 901571.","DOI":"10.3389\/fphys.2022.901571"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hoekstra M, van Ginneken ACG, Wilders R, Verkerk AO. HCN4 current during human sinoatrial node-like action potentials. Prog Biophys Mol Biol 2021; 166: 105-18.","DOI":"10.1016\/j.pbiomolbio.2021.05.006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yu HD, Xia S, Zha CQ, Deng SB, Du JL, She Q. Spironolactone regulates HCN protein expression through micro-RNA-1 in rats with myocardial infarction. J Cardiovasc Pharmacol 2015; 65: 587-92.","DOI":"10.1097\/FJC.0000000000000227"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Li M, Maljevic S, Phillips AM, <i>et al<\/i>. Gain-of-function HCN2 variants in genetic epilepsy. Hum Mutat 2018; 39: 202-9.","DOI":"10.1002\/humu.23357"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sartiani L, Romanelli MN, Mugelli A, Cerbai E. Updates on HCN channels in the heart: function, dysfunction and pharmacology. Curr Drug Targets 2015; 16: 868-76.","DOI":"10.2174\/1389450116666150531152047"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang J, Yang YM, Li Y, <i>et al<\/i>. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression. J Cardiovasc Electrophysiol 2019; 30: 242-52.","DOI":"10.1111\/jce.13772"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Suffredini S, Stillitano F, Comini L, <i>et al<\/i>. Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol 2012; 165: 1457-66.","DOI":"10.1111\/j.1476-5381.2011.01627.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Greene D, Kang S, Kosenko A, Hoshi N. Adrenergic regulation of HCN4 channel requires protein association with \u03b22-adrenergic receptor. J Biol Chem 2012; 287: 23690-7.","DOI":"10.1074\/jbc.M112.366955"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Brandt MC, Endres-Becker J, Zagidullin N, <i>et al<\/i>. Effects of KCNE2 on HCN isoforms: distinct modulation of membrane expression and single channel properties. Am J Physiol Heart Circ Physiol 2009; 297: H355-63.","DOI":"10.1152\/ajpheart.00154.2009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Anantharam A, Abbott GW. Does hERG coassemble with a beta subunit? Evidence for roles of MinK and MiRP1. Novartis Found Symp 2005; 266: 100-12.","DOI":"10.1002\/047002142X.ch9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lu Y, Mahaut-Smith MP, Huang CL, Vandenberg JI. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6. J Physiol 2003; 551: 253-62.","DOI":"10.1113\/jphysiol.2003.046045"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Qu J, Kryukova Y, Potapova IA, <i>et al<\/i>. MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem 2004; 279: 43497-502.","DOI":"10.1074\/jbc.M405018200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Stillitano F, Lonardo G, Zicha S, <i>et al<\/i>. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 2008; 45: 289-99.","DOI":"10.1016\/j.yjmcc.2008.04.013"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-330\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:10:57Z","timestamp":1706933457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-330\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-330","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"23-330"}}